Rury R. Holman
- Endocrinology, Diabetes and Metabolism top 0.01%
- Diabetes Treatment and Management 184
- Diabetes Management and Research 127
- Diabetes, Cardiovascular Risks, and Lipoproteins 81
- Nephrology top 0.1%
- Family Practice top 0.2%
-
- Cardiovascular Function and Risk Factors 38
- Surgery top 0.1%
- Pancreatic function and diabetes 35
-
- Metabolism, Diabetes, and Cancer 64
-
- Pharmacology and Obesity Treatment 27
-
- Diabetes and associated disorders 26
- Co-authors
- David R. MatthewsH. A. W. NeilSanjoy K. PaulM. Angelyn BethelBernard ZinmanJohn B. BuseIrene StrattonMayer B. Davidson
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Rury R. Holman
339 papers receiving 38.4k citations
Hit Papers
Peers
Comparison fields: 5 of 178
- Endocrinology, Diabetes and Metabolism 29.6k
- Nephrology 2.2k
- Family Practice 560
- Cardiology and Cardiovascular Medicine 5.7k
- Surgery 9.2k
Countries citing papers authored by Rury R. Holman
This map shows the geographic impact of Rury R. Holman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rury R. Holman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rury R. Holman more than expected).
Fields of papers citing papers by Rury R. Holman
This network shows the impact of papers produced by Rury R. Holman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rury R. Holman. The network helps show where Rury R. Holman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rury R. Holman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 12 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 9 | |
| 7 | 2022 | 20 | |
| 8 | 2022 | 27 | |
| 9 | 2020 | 62 | |
| 10 | 2020 | 5 | |
| 11 | 2020 | 25 | |
| 12 | 2019 | 68 | |
| 13 | 2019 | 8 | |
| 14 | 2018 | 24 | |
| 15 | 2018 | 8 | |
| 16 | 2018 | 49 | |
| 17 | 2017 | 4 | |
| 18 | Metformin as first choice in oral diabetes treatment: the UKPDS experience. | 2007 | 71 |
| 19 | 1998 | 346 | |
| 20 | 1996 | 35 |
About Rury R. Holman
Rury R. Holman is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Family Practice, having authored 350 papers that have together received 40.3k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (184 papers), Diabetes Management and Research (127 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (81 papers), Metabolism, Diabetes, and Cancer (64 papers), Cardiovascular Function and Risk Factors (38 papers), Pancreatic function and diabetes (35 papers), Pharmacology and Obesity Treatment (27 papers) and Diabetes and associated disorders (26 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (29.6k citations), Nephrology (2.2k citations) and Family Practice (560 citations). Rury R. Holman has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include David R. Matthews, H. A. W. Neil, Sanjoy K. Paul, M. Angelyn Bethel, Bernard Zinman, John B. Buse, Irene Stratton, Mayer B. Davidson, David M. Nathan and R. C. Turner. Their work appears in journals such as New England Journal of Medicine, The Lancet and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.